Show newer

RT @EUScienceInnov: Addressing the needs of Young is an EU priority!

For the 1st time, we're organising an event to give them the chance to share their experiences and interact with each other.

Join us and be an integral part of this conference on 7 February! 👇

🐦🔗: n.respublicae.eu/EMA_News/stat

| Last Friday we have proposed a revised regulatory timeline to:

🔸enable industry to continue producing essential medical devices
🔸reduce any short-term risk of shortages
🔸safeguard access for patients most in need


RT @EU_Health: Medical Devices Regulation: Despite considerable progress on implementation, the transition to the new rules is slower than anticipated.

Today we're proposing legislation that will support ongoing efforts…

🐦🔗: n.respublicae.eu/EU_Health/sta

assessment of the XBB.1.5 sub-lineage.

(...) This variant could have an increasing effect on the number of cases in the EU/EEA, but not within the coming month as it is currently only present in the EU/EEA at very low levels. (...)

ecdc.europa.eu/en/news-events/

🐦🔗: n.respublicae.eu/ECDC_EU/statu

Given the rapidly developing situation in China and a lack of reliable data, the Committee has issued an opinion emphasising the need for a common, phased & proportionate response, following the IPCR
Text here: europa.eu/!DmTCcT

1/3

🐦🔗: n.respublicae.eu/EU_Health/sta

is virus that evolves quickly and unpredictably.

Yet, we know that vaccination and booster doses are safe.
They also continue to protect people from severe, hospitalisation and death.

Take a moment to check you are fully protected, as per your national recommendations.

🐦🔗: n.respublicae.eu/EU_Health/sta

Check out the latest reports and studies funded under the 3rd health programme - you will learn more about:

🔵 EU vaccination card
🔵 Public procurement of
🔵 Pricing policies on food and beverages

...and other topics!

🐦🔗: n.respublicae.eu/EU_HaDEA/stat

Today 🇪🇺 Health Security Committee converged on action including:

▶️Pre-departure testing for travellers from China
▶️Stepped up wastewater monitoring
▶️Increased domestic surveillance

Discussion continues tomorrow in IPCR.

🇪🇺 unity remains our strongest tool against COVID.

🐦🔗: n.respublicae.eu/SKyriakidesEU

Also in 2⃣0⃣2⃣3⃣: will remain our biggest-ever investment in public health.

With a budget of EUR 735,8 million, it will allow for swift progress on priority actions linked to further development of the EU

Have a look at this year's work programme ⬇

🐦🔗: n.respublicae.eu/EU_Health/sta

Are you looking for funding opportunities to support your ideas on ?

📌Don't miss the the Info Days to learn about the new topics and calls under the

🗓️17 - 18 January 2023

research-innovation-community.

🐦🔗: n.respublicae.eu/EU_HaDEA/stat

!
Impact of surge in China cases on epidemiological situation in EU/EEA.

The number of cases has reached a record high in China, peaking on 2.12.22. In the past three weeks, incidence has fallen, likely also due to a lower testing.

ecdc.europa.eu/en/news-events/

🐦🔗: n.respublicae.eu/ECDC_EU/statu

EU countries agreed on a coordinated approach to the changing situation at today's Committee meeting, including implications for increased travel from China.

This feeds into tomorrow's integrated political crisis response (IPCR) meeting

🐦🔗: n.respublicae.eu/EU_Health/sta

As of 🗓️31 January 2023, sponsor will have to use the Clinical Trials Information System and follow the same process to apply for the authorisation of a clinical trial in the .

Learn more from the video 👇

🐦🔗: n.respublicae.eu/EMA_News/stat

Only a month ago we've adopted our new to:

🔸deliver better health for all
🔸strengthen health systems & advance universal health coverage
🔸prevent & combat health threats, applying a approach


🐦🔗: n.respublicae.eu/EU_Health/sta

RT @hans_kluge: 4/
Living with COVID is our long-term global reality.

The virus will continue to change with new variants possible.

We can safeguard ourselves and those around us via sensible personal hygiene & protective measures - including getting vaccinated, particularly the vulnerable.

🐦🔗: n.respublicae.eu/EMA_News/stat

The pandemic had a dramatic impact on people’s lives around the world.

In 2019-2021, COVID-19 has reduced life expectancy in almost all European countries.

Download the full 'Health at a Glance: Europe 2022'-report:
europa.eu/!fwx6XQ


@OECD_Social

🐦🔗: n.respublicae.eu/EU_Health/sta

Are you an academic sponsor 🎓 or a non-profit organisation developing advanced therapy medicines? Are you seeking regulatory support? 💊💉

Join EMA’s pilot for European academic and non-profit developers of advanced therapy medicinal products ().

🐦🔗: n.respublicae.eu/EMA_News/stat

EMA has approved 8⃣6⃣ biosimilars that help treating serious diseases such as and .

All EU-approved 🇪🇺 biosimilars are interchangeable with their reference medicine or an equivalent biosimilar ✅

Read more!

🐦🔗: n.respublicae.eu/EMA_News/stat

Entering into force TODAY!

We are building a stronger 🇪🇺 , including:

✅New Serious Cross-Border Health Threats Regulation
✅Extended mandate for @ECDC_EU
✅New Emergency Framework Regulation

Further strengthening our legal framework

🐦🔗: n.respublicae.eu/EU_Health/sta

: Where do we stand?

✅ 7 authorisations completed
✅ 4 approved
✅ 4 virus strains targeted – Wuhan, Beta, Omicron BA.1, Omicron BA. 4-5

🐦🔗: n.respublicae.eu/EMA_News/stat

Are you a clinical trial sponsor? With the Clinical Trials Information System, you will be able to apply for authorisations in up to 30 EU/EEA countries through a single application.

There is a transition period for this. Learn more!

🐦🔗: n.respublicae.eu/EMA_News/stat

Show older
Mastodon

A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.